Vaughan, C. A., Singh, S., Subler, M. A., Windle, J. J., Inoue, K., Fry, E. A., . . . Deb, S. (2021). The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3. Nature Portfolio.
Cita Chicago Style (17a ed.)Vaughan, Catherine A., et al. The Oncogenicity of Tumor-derived Mutant P53 Is Enhanced by the Recruitment of PLK3. Nature Portfolio, 2021.
Cita MLA (8a ed.)Vaughan, Catherine A., et al. The Oncogenicity of Tumor-derived Mutant P53 Is Enhanced by the Recruitment of PLK3. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.